Valganvir S.K. 50 mg/ml is indicated for:Adult Patients:Treatment of Cytomegalovirus (CMV) Retinitis: Valganvir S.K. 50 mg/ml is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS)Prevention of CMV Disease: Valganvir S.K. 50 mg/ml is indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at high risk.Pediatric Patients:Prevention of CMV Disease: Valganvir S.K. 50 mg/ml is indicated for the prevention of CMV disease in kidney transplant patients (4 months to 16 years of age) and heart transplant patients (1 month to 16 years of age) at high risk.